Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Quest Diagnostics (DGX – Research Report) and Sarepta Therapeutics (SRPT – Research Report ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Sarepta Therapeutics (SRPT) is under Wall Street’s microscope right now.Shares dropped by 49% in a single session last week, following the release of disappointing clinical trial results ...

Detailed price information for Alpha Teknova Inc (TKNO-Q) from The Globe and Mail including charting and trades.

Sarepta Therapeutics Inc. shares lost more than half their value in after-hours trading Thursday, after the company said a drug candidate produced mixed results in a clinical study.

14 analysts have expressed a variety of opinions on Sarepta Therapeutics (NASDAQ: ... Analyst Expectations For Sarepta Therapeutics's Future November 25, 2024 — 08:01 am EST.

A key issue, to hear the analyst team tell it, is what happens beyond Catalent’s current fiscal year. Sarepta already has a “meaningful supply” of Elevidys doses on hand from the last few ...

On Wednesday, Goldman Sachs reaffirmed its Buy rating and $100.00 price target for Sarepta Therapeutics (NASDAQ: SRPT), following a meeting with Dr. Vinay Prasad, the newly-appointed FDA CBER ...

Explore Sarepta Therapeutics analyst ratings and price targets (NASDAQ:SRPT) on Benzinga. Stay updated on expert opinions and forecasts for SRPT stock.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sarepta Therapeutics (SRPT – Research Report), Intercept Pharma (ICPT – Research Report) and ...

Sarepta Therapeutics (SRPT) is under Wall Street’s microscope right now.Shares dropped by 49% in a single session last week, following the release of disappointing clinical trial results ...